NCT00004924View on ClinicalTrials.gov

Paclitaxel and Irinotecan in Treating Patients With Advanced Non-small Cell Lung Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

March 31, 1999

Study Completion Date

February 28, 2006

Conditions
Lung Cancer
Interventions
DRUG

irinotecan hydrochloride

DRUG

paclitaxel

Trial Locations (2)

06520-8028

Yale Comprehensive Cancer Center, New Haven

06790

Northwestern Connecticut Oncology-Hematology Associates - Torrington, Torrington

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Yale University

OTHER

NCT00004924 - Paclitaxel and Irinotecan in Treating Patients With Advanced Non-small Cell Lung Cancer | Biotech Hunter | Biotech Hunter